Globavir Biosciences

Globavir Biosciences

A biopharmaceutical company creating novel therapeutics and diagnostic tool for treating infectious disease.

Globavir Biosciences is a biopharmaceutical company creating novel therapeutics and diagnostic tool for treating infectious disease that is headquartered in Los Altos, California and was founded in 2011 by Shalabh Gupta and Vijay Pande. The company is focused on commercializing re-purposed drugs for controlling infectious diseases such as coronavirus, dengue fever, ebola, and Chikungunya. Their lead drug candidate is called GBV-006 and is a combination of two drugs approved by the FDA for affecting viral load and mortality of viral infections.

Partnerships

Bio-Rad Laboratories

On October 17, 2016 Globavir Biosciences announced entering a partnership with Bio-Rad Laboratories to licence Globavir's PanGlob Dengue detection technology. There were no financial details of the partnership and licensing agreement between the two companies.

Funding

Seed

On November 12, 2012 Globavir Biosciences announced raising $2 million in seed funding from undisclosed investors.

Venture

On January 21, 2015 Globavir Biosciences announced raising $4 million in venture funding from StartX, Stanford University Venture Fund, and Sorrento Therapeutics.

Venture

On September 20, 2016 Globavir Biosciences announced raising $1.5 million in venture funding from undisclosed investors.

Timeline

October 17, 2016

Partnership with Bio-Rad Laboratories

On October 17, 2016 Globavir Biosciences announced entering a partnership with Bio-Rad Laboratories to licence Globavir's PanGlob Dengue detection technology. There were no financial details of the partnership and licensing agreement between the two companies.

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
Globavir Biosciences funding round, January 2015
Venture round
4,000,000
January 21, 2015
StartX
Globavir Biosciences funding round, September 2016
Venture round
1,500,000
September 20, 2016
Globavir Biosciences funding round, November 2012
Seed round
2,000,000
November 12, 2012
3 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.